Makoto Oka

448 total citations
24 papers, 388 citations indexed

About

Makoto Oka is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Makoto Oka has authored 24 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 12 papers in Molecular Biology and 5 papers in Organic Chemistry. Recurrent topics in Makoto Oka's work include Neurotransmitter Receptor Influence on Behavior (8 papers), Receptor Mechanisms and Signaling (7 papers) and Neuroscience and Neuropharmacology Research (5 papers). Makoto Oka is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (8 papers), Receptor Mechanisms and Signaling (7 papers) and Neuroscience and Neuropharmacology Research (5 papers). Makoto Oka collaborates with scholars based in Japan. Makoto Oka's co-authors include Satoshi Kurumiya, Kiyoshi Furukawa, Masanao Shimizu, Atsuko Kita, Tomoko Kinoshita, Hitoshi Uno, Chiaki Kamei, Yasutaka Nagai, Tadahiko Karasawa and Katsuhiko Hino and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Makoto Oka

23 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Makoto Oka Japan 12 196 152 87 50 30 24 388
M. Sandier United Kingdom 8 169 0.9× 126 0.8× 76 0.9× 40 0.8× 33 1.1× 8 405
Seid Mirsadeghi United States 8 290 1.5× 207 1.4× 100 1.1× 95 1.9× 39 1.3× 11 482
Moshe Gavish Israel 10 193 1.0× 164 1.1× 34 0.4× 26 0.5× 34 1.1× 14 355
K.C. Rice United States 9 236 1.2× 239 1.6× 62 0.7× 34 0.7× 25 0.8× 16 458
S. Hasan Tahir United States 6 288 1.5× 190 1.3× 63 0.7× 95 1.9× 43 1.4× 8 446
Junki Katsube Japan 10 178 0.9× 125 0.8× 117 1.3× 35 0.7× 11 0.4× 50 413
Rita Dost Germany 9 184 0.9× 191 1.3× 90 1.0× 84 1.7× 14 0.5× 15 390
E. Chanut France 11 205 1.0× 188 1.2× 22 0.3× 43 0.9× 18 0.6× 16 437
A. Cordi France 10 207 1.1× 200 1.3× 60 0.7× 26 0.5× 35 1.2× 15 365
Kenneth L. Hauser United States 7 212 1.1× 239 1.6× 149 1.7× 35 0.7× 24 0.8× 9 594

Countries citing papers authored by Makoto Oka

Since Specialization
Citations

This map shows the geographic impact of Makoto Oka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Oka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Oka more than expected).

Fields of papers citing papers by Makoto Oka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makoto Oka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Oka. The network helps show where Makoto Oka may publish in the future.

Co-authorship network of co-authors of Makoto Oka

This figure shows the co-authorship network connecting the top 25 collaborators of Makoto Oka. A scholar is included among the top collaborators of Makoto Oka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makoto Oka. Makoto Oka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kita, Atsuko, et al.. (2004). Antianxiety and antidepressant‐like effects of AC‐5216, a novel mitochondrial benzodiazepine receptor ligand. British Journal of Pharmacology. 142(7). 1059–1072. 114 indexed citations
2.
Shimizu, Isao, et al.. (2003). Urodynamics in a rat neurogenic bladder model with a unilateral electrolytic lesion of the basal forebrain. British Journal of Urology. 91(9). 861–867. 4 indexed citations
3.
Yoshikawa, Takashi, Naoyuki Yoshida, & Makoto Oka. (2001). The broad‐spectrum anti‐emetic activity of AS‐8112, a novel dopamine D2, D3 and 5‐HT3 receptors antagonist. British Journal of Pharmacology. 133(2). 253–260. 17 indexed citations
4.
Shimizu, Isao, et al.. (2001). Pharmacological actions of AH-9700 on micturition reflex in anesthetized rats. European Journal of Pharmacology. 412(2). 171–179. 5 indexed citations
5.
Yoshikawa, Takashi, Naoyuki Yoshida, & Makoto Oka. (2001). Central antiemetic effects of AS-8112, a dopamine D2, D3, and 5-HT3 receptor antagonist, in ferrets. European Journal of Pharmacology. 431(3). 361–364. 4 indexed citations
6.
Shimizu, Isao, et al.. (2001). Effects of AH-9700, (+)-pentazocine, DTG and oxybutynin on micturition in anesthetized rats with acetone-induced cystitis. Life Sciences. 69(14). 1691–1697. 4 indexed citations
7.
Tsuda, Yuko, Toshio Yokoi, Daniel Sharon, et al.. (2000). Development of μ-Receptor Selective Opioid Mimetics Derived from Endomorphin Sequences. 1999. 437–440. 1 indexed citations
8.
Shimizu, Isao, et al.. (2000). Effects of (+)‐pentazocine and 1,3‐di‐o‐tolylguanidine (DTG), sigma (σ) ligands, on micturition in anaesthetized rats. British Journal of Pharmacology. 131(3). 610–616. 15 indexed citations
9.
Noda, Yukihiro, et al.. (1995). Effects of RGH-2202 on behavioral deficits after focal cerebral ischemia in rats. Pharmacology Biochemistry and Behavior. 52(4). 695–699. 16 indexed citations
10.
Oka, Makoto, Yasutaka Noda, Katsuo Furukawa, et al.. (1993). Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties.. Journal of Pharmacology and Experimental Therapeutics. 264(1). 158–165. 48 indexed citations
11.
Noda, Yukihiro, et al.. (1991). Involvement of central cholinergic mechanism in RU-24969-induced behavioral deficits. Pharmacology Biochemistry and Behavior. 38(2). 441–446. 18 indexed citations
12.
13.
Hino, Katsuhiko, et al.. (1988). A novel class of potential central nervous system agents. 3-Phenyl-2-(1-piperazinyl)-5H-1-benzazepines. Journal of Medicinal Chemistry. 31(1). 107–117. 21 indexed citations
14.
Matsuno, Yukihiko, et al.. (1986). General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 2nd communication: Effects on central nervous and sensory systems and on the other functions.. PubMed. 36(1). 62–8. 1 indexed citations
15.
Oka, Makoto, et al.. (1985). Differential effects of haloperidol decanoate, a long-acting neuroleptic, in behavioral and biochemical tests.. PubMed. 277(2). 289–302. 4 indexed citations
16.
Oka, Makoto, et al.. (1979). Differential antagonism of antiavoidance, cataleptic and ptotic effects of neuroleptics by biperiden. The Japanese Journal of Pharmacology. 29(3). 435–445. 9 indexed citations
17.
Nagai, Yasutaka, et al.. (1979). Synthesis of 2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole derivatives and their central nervous system activities. Journal of Medicinal Chemistry. 22(6). 677–683. 15 indexed citations
18.
Kamei, Chiaki, et al.. (1978). Effects of Antiepileptics on Both Behavioral and Electrographic Seizure Patterns Induced by Maximal Electroshock in Rats. Epilepsia. 19(6). 625–636. 16 indexed citations
19.
Oka, Makoto & Masanao Shimizu. (1975). A SIMPLE AVOIDANCE PROCEDURE FOR TESTING PSYCHOTROPIC DRUGS IN MICE. The Japanese Journal of Pharmacology. 25(2). 121–127. 4 indexed citations
20.
Kamei, Chiaki, et al.. (1975). Effects of Antidepressant Drugs on Amygdaloid After-Discharge in Rats. The Japanese Journal of Pharmacology. 25(4). 359–365. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Sandier Breakdown of academic impact, for papers by Seid Mirsadeghi Breakdown of academic impact, for papers by Moshe Gavish Breakdown of academic impact, for papers by K.C. Rice Breakdown of academic impact, for papers by S. Hasan Tahir Breakdown of academic impact, for papers by Junki Katsube Breakdown of academic impact, for papers by Rita Dost Breakdown of academic impact, for papers by E. Chanut Breakdown of academic impact, for papers by A. Cordi Breakdown of academic impact, for papers by Kenneth L. Hauser
Rankless by CCL
2026